Presented by: University of Kentucky Department of Pathology

“Operating a Successful Cytopathology Laboratory and lessons learned from  Directorship experience”

Treeva Jassim, MD

Faculty at Tufts Medical Center

Assistant Professor at Tufts University-School of Medicine

Boston, MA

          Thursday, September 3, 2026

12:00 – 1:00pm

In-Person MS 147 or Zoom: https://us06web.zoom.us/j/88974250308

Passcode: 710932

At the completion of this lecture attendees should be able to:

• Describe key principles for developing and maintaining a successful cytopathology laboratory.
• Identify practical strategies for optimizing laboratory workflow, quality, and team performance.
• Evaluate lessons learned from cytopathology laboratory directorship and apply them to everyday practice.

Disclosure of Financial Interest Summary to Learners

All planners, faculty, and others in control of educational content are required to disclose all their financial
relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one
whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by
or on patients. Financial relationships are relevant if the educational content an individual can control is related
to the business lines or products of the ineligible company.

None of the planners, faculty, and others in control of educational content for this educational activity have a
relevant financial relationship(s) to disclose with ineligible companies.

The material presented in this course represents information obtained from the scientific literature as well as
the clinical experiences of the speakers. In some cases, the presentations might include a discussion of
investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will
inform the audience when they are discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial
bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but
it is made to provide participants with information that might be of potential importance to their evaluation of a
presentation.